Article | December 12, 2016

Barriers To Increased Participation Of Minorities In Clinical Trials

Barriers To Increased Participation Of Minorities In Clinical Trials

Clinical trials are at the heart of the process for bringing new medicines to patients. One of the most critical aspects to the conduct of any clinical trial is identifying the right group of people to include in the study. Unfortunately, many of the clinical trials conducted in the United States suffer from a lack of diversity, with minority populations being consistently underrepresented. In addition, there is often a lack of consideration of cultural and genetic factors which are particular to Asian, African-American, Hispanic, and other minorities that may influence results. This ethnic diversity gap can lead to less than ideal development of new medicines and can further exacerbate minority health issues.

VIEW THE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Clinical Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: